These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34432550)

  • 1. Association of Metabolic Syndrome and Chronic Kidney Disease in Moroccan Adult Population.
    Moustakim R; Mziwira M; El Ayachi M; Belahsen R
    Metab Syndr Relat Disord; 2021 Oct; 19(8):460-468. PubMed ID: 34432550
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between metabolic syndrome and chronic kidney disease in a Chinese urban population.
    Chen J; Kong X; Jia X; Li W; Wang Z; Cui M; Xu D
    Clin Chim Acta; 2017 Jul; 470():103-108. PubMed ID: 28501388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Metabolic Syndrome with Chronic Kidney Disease in Elderly Japanese Women: Comparison by Estimation of Glomerular Filtration Rate from Creatinine, Cystatin C, and Both.
    Kurata M; Tsuboi A; Takeuchi M; Fukuo K; Kazumi T
    Metab Syndr Relat Disord; 2016 Feb; 14(1):40-5. PubMed ID: 26535975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
    Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance.
    Zammit AR; Katz MJ; Derby C; Bitzer M; Lipton RB
    PLoS One; 2015; 10(10):e0139369. PubMed ID: 26431218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and metabolic risk factors of chronic kidney disease among a Mexican adult population: a cross-sectional study in primary healthcare medical units.
    Alvarez Paredes AR; Gómez García A; Alvarez Paredes MA; Velázquez N; Ojeda Bolaños DC; Padilla Sandoval MS; Gallardo JM; Muñoz Cortés G; Reyes Granados SC; Rodríguez Morán MF; Tripp J; Lopez Pineda A; Alvarez Aguilar C
    PeerJ; 2024; 12():e17817. PubMed ID: 39099652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study.
    Yang T; Chu CH; Hsu CH; Hsieh PC; Chung TC; Bai CH; You SL; Hwang LC; Lin CM; Sun CA
    Nephrology (Carlton); 2012 Aug; 17(6):532-8. PubMed ID: 22487238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and chronic kidney disease as risk factors of osteoporosis.
    Shin JH; Kim SH; Yu SH
    Clin Nephrol; 2014 Jan; 81(1):1-8. PubMed ID: 24356037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome components as markers to prognosticate the risk of developing chronic kidney disease: evidence-based study with 6492 individuals.
    Zomorrodian D; Khajavi-Rad A; Avan A; Ebrahimi M; Nematy M; Azarpazhooh MR; Emamian M; Sadeghzade M; Mirhafez SR; Mohammadi M; Mousavi M; Esmaeili H; Moohebati M; Parizadeh MR; Ferns GA; Ghayour-Mobarhan M
    J Epidemiol Community Health; 2015 Jun; 69(6):594-8. PubMed ID: 25631859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HbA1c Levels Are Associated with Chronic Kidney Disease in a Non-Diabetic Adult Population: A Nationwide Survey (KNHANES 2011-2013).
    Kang SH; Jung DJ; Choi EW; Cho KH; Park JW; Do JY
    PLoS One; 2015; 10(12):e0145827. PubMed ID: 26716684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic kidney disease in adults with metabolic syndrome.
    Emem-Chioma PC; Siminialayi IM; Wokoma FS
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):949-54. PubMed ID: 21912024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly Japanese.
    Kawamoto R; Akase T; Ninomiya D; Kumagi T; Kikuchi A
    Int Urol Nephrol; 2019 Dec; 51(12):2285-2294. PubMed ID: 31642000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of association of glomerular filtration rate with metabolic syndrome in a community-based population using the CKD-EPI and MDRD study equations.
    Hong N; Oh J; Lee YH; Youn JC; Park S; Lee SH; Jang Y; Chung N; Kim S; Jee SH; Kang SM
    Clin Chim Acta; 2014 Feb; 429():157-62. PubMed ID: 24360849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Syndrome and Inflammation from Young to Mid-Adulthood and Subclinical Kidney Damage in Middle-Aged Australians.
    Liu C; Tian J; Jose MD; Dwyer T; Venn AJ
    Metab Syndr Relat Disord; 2023 Oct; 21(8):460-467. PubMed ID: 37579129
    [No Abstract]   [Full Text] [Related]  

  • 16. Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study.
    Ma A; Liu F; Wang C; Liang K; Yan F; Hou X; Liu J; Chen L
    Int Urol Nephrol; 2018 Dec; 50(12):2239-2244. PubMed ID: 30182294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross-sectional analysis in Chongqing, China.
    Liu M; He K; Wu Y; Yu Q; Sun N; Teng X; Meng X; Yuan J; Yang H
    HIV Med; 2024 May; 25(5):529-539. PubMed ID: 38158594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study.
    DeBoer MD; Filipp SL; Musani SK; Sims M; Okusa MD; Gurka M
    Kidney Blood Press Res; 2018; 43(2):555-567. PubMed ID: 29642060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The number of metabolic syndrome components is a good risk indicator for both early- and late-stage kidney damage.
    Okada R; Yasuda Y; Tsushita K; Wakai K; Hamajima N; Matsuo S
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):277-85. PubMed ID: 24418372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metabolic syndrome on resting energy expenditure in patients with chronic kidney disease.
    Rodrigues CQD; Santos JAP; Quinto BMR; Marrocos MSM; Teixeira AA; Rodrigues CJO; Batista MC
    Clin Nutr ESPEN; 2016 Oct; 15():107-113. PubMed ID: 28531773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.